{"count": 25, "results": [{"_id": "35720480", "pmid": 35720480, "pmcid": "PMC9178677", "title": "Metformin: A promising drug for human cancers", "journal": "Oncol Lett", "authors": ["Wu H", "Huang D", "Zhou H", "Sima X", "Wu Z", "Sun Y", "Wang L", "Ruan Y", "Wu Q", "Wu F", "She T", "Chu Y", "Huang Q", "Ning Z", "Zhang H"], "date": "2022-05-12T00:00:00Z", "doi": "10.3892/ol.2022.13325", "meta_date_publication": "2022 Jul", "meta_volume": "24", "meta_issue": "1", "meta_pages": "204", "score": 50263.36, "text_hl": "These results provide a theoretical basis for further application of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in the treatment of @<m>DISEASE_Esophageal_Neoplasms</m> @DISEASE_MESH:D004938 @@@esophageal cancer@@@.", "citations": {"NLM": "Wu H, Huang D, Zhou H, Sima X, Wu Z, Sun Y, Wang L, Ruan Y, Wu Q, Wu F, She T, Chu Y, Huang Q, Ning Z, Zhang H. Metformin: A promising drug for human cancers Oncol Lett. 2022 Jul;24(1):204. PMID: 35720480", "BibTeX": "@article{35720480, title={Metformin: A promising drug for human cancers}, author={Wu H and Huang D and Zhou H and Sima X and Wu Z and Sun Y and Wang L and Ruan Y and Wu Q and Wu F and She T and Chu Y and Huang Q and Ning Z and Zhang H}, journal={Oncol Lett}, volume={24}, number={1}, pages={204}}"}}, {"_id": "37314979", "pmid": 37314979, "pmcid": "PMC10322653", "title": "Diabetes, metformin use, and survival in esophageal cancer: a population-based cohort study", "journal": "JNCI Cancer Spectr", "authors": ["Wang QL", "Santoni G", "Lagergren J"], "date": "2023-06-14T00:00:00Z", "doi": "10.1093/jncics/pkad043", "meta_date_publication": "2023 Jun 14", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50261.13, "text_hl": "@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetes@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use, and survival in @<m>DISEASE_Esophageal_Neoplasms</m> @DISEASE_MESH:D004938 @@@esophageal cancer@@@: a population-based cohort study", "citations": {"NLM": "Wang QL, Santoni G, Lagergren J. Diabetes, metformin use, and survival in esophageal cancer: a population-based cohort study JNCI Cancer Spectr. 2023 Jun 14;():. PMID: 37314979", "BibTeX": "@article{37314979, title={Diabetes, metformin use, and survival in esophageal cancer: a population-based cohort study}, author={Wang QL and Santoni G and Lagergren J}, journal={JNCI Cancer Spectr}}"}}, {"_id": "34398301", "pmid": 34398301, "pmcid": "PMC8921146", "title": "Dynamic switch of immunity and antitumor effects of metformin in rat spontaneous esophageal carcinogenesis", "journal": "Cancer Immunol Immunother", "authors": ["Takei R", "Miyashita T", "Takada S", "Tajima H", "Ninomiya I", "Takamura H", "Fushida S", "Harashima A", "Munesue S", "Yagi S", "Inaki N", "Ohta T", "Yamamoto Y"], "date": "2022-04-01T00:00:00Z", "doi": "10.1007/s00262-021-03027-x", "meta_date_publication": "2022 Apr", "meta_volume": "71", "meta_issue": "4", "meta_pages": "777-789", "score": 50260.36, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ treatment inhibits development of @DISEASE_Barrett_Esophagus @DISEASE_MESH:D001471 @@@BE@@@ and @<m>DISEASE_Esophageal_Neoplasms</m> @DISEASE_MESH:D004938 @@@EC@@@", "citations": {"NLM": "Takei R, Miyashita T, Takada S, Tajima H, Ninomiya I, Takamura H, Fushida S, Harashima A, Munesue S, Yagi S, Inaki N, Ohta T, Yamamoto Y. Dynamic switch of immunity and antitumor effects of metformin in rat spontaneous esophageal carcinogenesis Cancer Immunol Immunother. 2022 Apr;71(4):777-789. PMID: 34398301", "BibTeX": "@article{34398301, title={Dynamic switch of immunity and antitumor effects of metformin in rat spontaneous esophageal carcinogenesis}, author={Takei R and Miyashita T and Takada S and Tajima H and Ninomiya I and Takamura H and Fushida S and Harashima A and Munesue S and Yagi S and Inaki N and Ohta T and Yamamoto Y}, journal={Cancer Immunol Immunother}, volume={71}, number={4}, pages={777-789}}"}}, {"_id": "39774829", "pmid": 39774829, "title": "Association of metformin use with risk and survival outcome of esophageal cancer in patients with diabetes: A systematic review and meta-analysis.", "journal": "PLoS One", "authors": ["Xie H", "Li M", "Chen Z", "Zheng Y"], "date": "2025-01-07T00:00:00Z", "doi": "10.1371/journal.pone.0310687", "meta_date_publication": "2025", "meta_volume": "20", "meta_issue": "1", "meta_pages": "e0310687", "score": 50257.98, "text_hl": "The combined findings revealed a significant association between the use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and a lower risk of @<m>DISEASE_Esophageal_Neoplasms</m> @DISEASE_MESH:D004938 @@@EC@@@ (OR, 0.87, P = 0.04). ", "citations": {"NLM": "Xie H, Li M, Chen Z, Zheng Y. Association of metformin use with risk and survival outcome of esophageal cancer in patients with diabetes: A systematic review and meta-analysis. PLoS One. 2025;20(1):e0310687. PMID: 39774829", "BibTeX": "@article{39774829, title={Association of metformin use with risk and survival outcome of esophageal cancer in patients with diabetes: A systematic review and meta-analysis.}, author={Xie H and Li M and Chen Z and Zheng Y}, journal={PLoS One}, volume={20}, number={1}, pages={e0310687}}"}}, {"_id": "32258099", "pmid": 32258099, "pmcid": "PMC7104266", "title": "Metformin's Effects on Apoptosis of Esophageal Carcinoma Cells and Normal Esophageal Epithelial Cells: An In Vitro Comparative Study", "journal": "Biomed Res Int", "authors": ["Peng J", "Jing X", "Wu J", "Hong D", "Hu X", "Wang Q", "Hu H", "Cai X"], "date": "2020-03-18T00:00:00Z", "doi": "10.1155/2020/1068671", "meta_date_publication": "2020", "meta_volume": "2020", "meta_issue": "", "meta_pages": "1068671", "score": 50257.742, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@'s Effects on Apoptosis of @<m>DISEASE_Esophageal_Neoplasms</m> @DISEASE_MESH:D004938 @@@Esophageal Carcinoma@@@ Cells and Normal Esophageal Epithelial Cells: An In Vitro Comparative Study", "citations": {"NLM": "Peng J, Jing X, Wu J, Hong D, Hu X, Wang Q, Hu H, Cai X. Metformin's Effects on Apoptosis of Esophageal Carcinoma Cells and Normal Esophageal Epithelial Cells: An In Vitro Comparative Study Biomed Res Int. 2020;2020():1068671. PMID: 32258099", "BibTeX": "@article{32258099, title={Metformin's Effects on Apoptosis of Esophageal Carcinoma Cells and Normal Esophageal Epithelial Cells: An In Vitro Comparative Study}, author={Peng J and Jing X and Wu J and Hong D and Hu X and Wang Q and Hu H and Cai X}, journal={Biomed Res Int}, volume={2020}, pages={1068671}}"}}, {"_id": "32507907", "pmid": 32507907, "title": "The effect of metformin on esophageal cancer risk in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.", "journal": "Clin Transl Oncol", "authors": ["Wu HD", "Zhang JJ", "Zhou BJ"], "date": "2021-02-01T00:00:00Z", "doi": "10.1007/s12094-020-02415-6", "meta_date_publication": "2021 Feb", "meta_volume": "23", "meta_issue": "2", "meta_pages": "275-282", "score": 50255.54, "text_hl": "METHODS: We searched clinical studies on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @<m>DISEASE_Esophageal_Neoplasms</m> @DISEASE_MESH:D004938 @@@esophageal cancer@@@ risk in PubMed, Embase, and the Cochrane Library. ", "citations": {"NLM": "Wu HD, Zhang JJ, Zhou BJ. The effect of metformin on esophageal cancer risk in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Clin Transl Oncol. 2021 Feb;23(2):275-282. PMID: 32507907", "BibTeX": "@article{32507907, title={The effect of metformin on esophageal cancer risk in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.}, author={Wu HD and Zhang JJ and Zhou BJ}, journal={Clin Transl Oncol}, volume={23}, number={2}, pages={275-282}}"}}, {"_id": "39975715", "pmid": 39975715, "title": "Causal relationship between type II diabetes mellitus, metformin, insulin, gliclazide, and esophageal cancer-insights from two-sample Mendelian randomization study and meta-analysis.", "journal": "J Thorac Dis", "authors": ["Lin Y", "Lin J", "Xu H", "Hong Z", "Kang M"], "date": "2025-01-24T00:00:00Z", "doi": "10.21037/jtd-24-1152", "meta_date_publication": "2025 Jan 24", "meta_volume": "17", "meta_issue": "1", "meta_pages": "243-253", "score": 50255.363, "text_hl": "Conclusions: Our findings indicate T2DM and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ are causally associated with diminished risk of @<m>DISEASE_Esophageal_Neoplasms</m> @DISEASE_MESH:D004938 @@@EC@@@, while no causal associations exist between @GENE_INS @GENE_3630 @@@insulin@@@, @CHEMICAL_Gliclazide @CHEMICAL_MESH:D005907 @@@gliclazide@@@, and @<m>DISEASE_Esophageal_Neoplasms</m> @DISEASE_MESH:D004938 @@@EC@@@.", "citations": {"NLM": "Lin Y, Lin J, Xu H, Hong Z, Kang M. Causal relationship between type II diabetes mellitus, metformin, insulin, gliclazide, and esophageal cancer-insights from two-sample Mendelian randomization study and meta-analysis. J Thorac Dis. 2025 Jan 24;17(1):243-253. PMID: 39975715", "BibTeX": "@article{39975715, title={Causal relationship between type II diabetes mellitus, metformin, insulin, gliclazide, and esophageal cancer-insights from two-sample Mendelian randomization study and meta-analysis.}, author={Lin Y and Lin J and Xu H and Hong Z and Kang M}, journal={J Thorac Dis}, volume={17}, number={1}, pages={243-253}}"}}, {"_id": "32646922", "pmid": 32646922, "title": "Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial.", "journal": "Clin Cancer Res", "authors": ["Wang S", "Lin Y", "Xiong X", "Wang L", "Guo Y", "Chen Y", "Chen S", "Wang G", "Lin P", "Chen H", "Yeung SJ", "Bremer E", "Zhang H"], "date": "2020-09-15T00:00:00Z", "doi": "10.1158/1078-0432.CCR-20-0113", "meta_date_publication": "2020 Sep 15", "meta_volume": "26", "meta_issue": "18", "meta_pages": "4921-4932", "score": 50254.01, "text_hl": "Low-Dose @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Reprograms the @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@Tumor@@@ Immune Microenvironment in @SPECIES_9606 @@@Human@@@ @<m>DISEASE_Esophageal_Neoplasms</m> @DISEASE_MESH:D004938 @@@Esophageal Cancer@@@: Results of a Phase II Clinical Trial.", "citations": {"NLM": "Wang S, Lin Y, Xiong X, Wang L, Guo Y, Chen Y, Chen S, Wang G, Lin P, Chen H, Yeung SJ, Bremer E, Zhang H. Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial. Clin Cancer Res. 2020 Sep 15;26(18):4921-4932. PMID: 32646922", "BibTeX": "@article{32646922, title={Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial.}, author={Wang S and Lin Y and Xiong X and Wang L and Guo Y and Chen Y and Chen S and Wang G and Lin P and Chen H and Yeung SJ and Bremer E and Zhang H}, journal={Clin Cancer Res}, volume={26}, number={18}, pages={4921-4932}}"}}, {"_id": "31821177", "pmid": 31821177, "title": "Association Between Metformin Use and Risk of Esophageal Squamous Cell Carcinoma in a Population-Based Cohort Study.", "journal": "Am J Gastroenterol", "authors": ["Wang QL", "Santoni G", "Ness-Jensen E", "Lagergren J", "Xie SH"], "date": "2020-01-01T00:00:00Z", "doi": "10.14309/ajg.0000000000000478", "meta_date_publication": "2020 Jan", "meta_volume": "115", "meta_issue": "1", "meta_pages": "73-78", "score": 50251.688, "text_hl": "A large prospective study is expected to elucidate the specific risk of the 90% subtype of @<m>DISEASE_Esophageal_Neoplasms</m> @DISEASE_MESH:D004938 @@@esophageal cancer@@@, @DISEASE_Esophageal_Squamous_Cell_Carcinoma @DISEASE_MESH:D000077277 @@@esophageal squamous cell carcinoma@@@ (@DISEASE_Esophageal_Squamous_Cell_Carcinoma @DISEASE_MESH:D000077277 @@@ESCC@@@), with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ therapy. ", "citations": {"NLM": "Wang QL, Santoni G, Ness-Jensen E, Lagergren J, Xie SH. Association Between Metformin Use and Risk of Esophageal Squamous Cell Carcinoma in a Population-Based Cohort Study. Am J Gastroenterol. 2020 Jan;115(1):73-78. PMID: 31821177", "BibTeX": "@article{31821177, title={Association Between Metformin Use and Risk of Esophageal Squamous Cell Carcinoma in a Population-Based Cohort Study.}, author={Wang QL and Santoni G and Ness-Jensen E and Lagergren J and Xie SH}, journal={Am J Gastroenterol}, volume={115}, number={1}, pages={73-78}}"}}, {"_id": "34929693", "pmid": 34929693, "title": "Chemoprevention of Oesophageal Squamous-Cell Carcinoma and Adenocarcinoma: A Multicentre Retrospective Cohort Study.", "journal": "Digestion", "authors": ["Arai J", "Niikura R", "Hayakawa Y", "Kawahara T", "Honda T", "Hasatani K", "Yoshida N", "Nishida T", "Sumiyoshi T", "Kiyotoki S", "Ikeya T", "Arai M", "Suzuki N", "Tsuji Y", "Yamada A", "Kawai T", "Koike K"], "date": "2022-01-01T00:00:00Z", "doi": "10.1159/000520924", "meta_date_publication": "2022", "meta_volume": "103", "meta_issue": "3", "meta_pages": "192-204", "score": 50245.855, "text_hl": "CONCLUSION: COX2Is, statins, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, and PPIs could help in prevention of @<m>DISEASE_Esophageal_Neoplasms</m> @DISEASE_MESH:D004938 @@@ESCC@@@, and @CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@aspirin@@@ and @CHEMICAL_Steroids @CHEMICAL_MESH:D013256 @@@steroids@@@ may be chemopreventive for both types of @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@oesophageal cancer@@@.", "citations": {"NLM": "Arai J, Niikura R, Hayakawa Y, Kawahara T, Honda T, Hasatani K, Yoshida N, Nishida T, Sumiyoshi T, Kiyotoki S, Ikeya T, Arai M, Suzuki N, Tsuji Y, Yamada A, Kawai T, Koike K. Chemoprevention of Oesophageal Squamous-Cell Carcinoma and Adenocarcinoma: A Multicentre Retrospective Cohort Study. Digestion. 2022;103(3):192-204. PMID: 34929693", "BibTeX": "@article{34929693, title={Chemoprevention of Oesophageal Squamous-Cell Carcinoma and Adenocarcinoma: A Multicentre Retrospective Cohort Study.}, author={Arai J and Niikura R and Hayakawa Y and Kawahara T and Honda T and Hasatani K and Yoshida N and Nishida T and Sumiyoshi T and Kiyotoki S and Ikeya T and Arai M and Suzuki N and Tsuji Y and Yamada A and Kawai T and Koike K}, journal={Digestion}, volume={103}, number={3}, pages={192-204}}"}}]}